Evidence map›Paper›PMID 39919446›Full record

ReviewVaccine2025

Realist review of low- to upper-middle-income country experiences on integration of HPV vaccination with other adolescent health services.

Mary Carol Jennings, Sarah Nabia, Christopher Morgan, Chinelo Cynthia Nduka, Julia Brotherton, Megan Holloway, Katharine Bagshaw, Paul Bloem, Chizoba Wonodi

Abstract readReview
In one paragraph

Review in Vaccine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mary Carol JenningsJhpiego, 1615 Thames St. #200, Baltimore, MD 21231, USA. Electronic address: MaryCarol.Jennings@Jhpiego.org.
Sarah NabiaUSAID's MOMENTUM Project, Country and Global Leadership, Washington, DC, USA; International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, 415 North Washington St, 5th Floor, Baltimore, MD 21231, USA. Electronic address: snabia1@jhu.edu.
Christopher MorganJhpiego, 1615 Thames St. #200, Baltimore, MD 21231, USA. Electronic address: Christopher.Morgan@jhpiego.org.
Chinelo Cynthia NdukaDepartment of Community Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria.
Julia BrothertonMelbourne School of Population and Global Health, University of Melbourne, Australia, Level 4, 207 Bouverie Street, University of Melbourne, Victoria 3010, Australia. Electronic address: jbrotherton@unimelb.edu.au.
Megan HollowayIndependent Consultant. London, UK.
Katharine BagshawPublic Health Institute, United States Agency for International Development's Global Health Training, Advisory, and Support Contract (GHTASC), Washington, DC 20024, USA. Electronic address: kbagshaw@phi.org.
Paul BloemWorld Health Organization, Av. Appia 20, 1202 Genève, Switzerland. Electronic address: bloemp@who.int.
Chizoba WonodiUSAID's MOMENTUM Project, Country and Global Leadership, Washington, DC, USA; International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, 415 North Washington St, 5th Floor, Baltimore, MD 21231, USA. Electronic address: cwonodi1@jhu.edu.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundIntegration of HPV vaccination with other adolescent health services may be associated with favorable programme outcomes including coverage, sustainability, and equitable delivery. Interest in such integrated approaches is building. However, the empirical evidence on how an integrated approach might be used to effectively deliver HPV vaccines and other adolescent health services has not been consolidated in a manner sufficient to inform policy and programmes.

methodsWe conducted a realist synthesis review of published experiences from low- to upper-middle-income countries. Experts were invited as review commissioners, informing development and iteration of a programme theory of change (TOC). Our search strategy queried three large academic peer-review databases, grey literature, and a "snowball" of citations from key reference articles. We extracted learnings from specific real-world country experiences, exploring theoretical constructs describing the context in which an integration mechanism may deliver intended outcomes.

resultsOf 1961 peer-reviewed articles and 16 grey literature articles identified, 8 articles met inclusion criteria, providing data from 6 country experiences to develop an iterated TOC. There were notable gaps in evidence regarding how an integrated approach might meet unique needs of underserved populations, including out of school youth and those affected by HIV. TOC iterations yielded 9 new factors and 4 discarded factors. Notable new factors included a multisectoral cooperation mechanism, linked to the use of a large number of other mechanisms, including integration of cost-sharing, supply chain distribution, and programme monitoring.

conclusionThis realist synthesis is to our knowledge the first review consolidating operational evidence on how an integrated approach might be used to effectively deliver HPV vaccines and other adolescent health services. Our iterated TOC provides a framework to guide future implementation research, to ensure attribution of observed effects to an integrated approach is merited - and to inform decision-making in adolescent immunization policy and programmes.

Indexed as

Adolescent Health ServicesImmunization ProgramsPapillomavirus InfectionsPapillomavirus VaccinesVaccinationAdolescentDeveloping CountriesFemaleHumansPapillomavirus Vaccines

Identifiers

PMID39919446
PMCPMC11878278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.